Trade Summary

5 days ago, Wengel Kathryn E, serving as EVP, Chief TO and Risk Officer at JOHNSON & JOHNSON (JNJ), sold 10,000 shares at $241.15 per share, for a total transaction value of $2,411,500.00. Following this transaction, Wengel Kathryn E now holds 114,288 shares of JNJ.

This sale represents a 8.05% decrease in Wengel Kathryn E's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 5:23 PM ET, 1 day after the trade was made.

JOHNSON & JOHNSON operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.